Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2015

01-12-2015 | Endocrine Tumors

Intraoperative Parathormone Monitoring Mitigates Age-Related Variability in Targeted Parathyroidectomy for Patients with Primary Hyperparathyroidism

Authors: Brian Bishop, BS, Bo Wang, MD, Punam P. Parikh, MD, John I. Lew, MD, FACS

Published in: Annals of Surgical Oncology | Special Issue 3/2015

Login to get access

Abstract

Background

Preoperative parathyroid localization studies, namely, sestamibi (MIBI) and surgeon-performed ultrasound (SUS), are commonly used for targeted parathyroidectomy (PTX) with intraoperative parathormone monitoring (IPM) in patients with primary hyperparathyroidism (pHPT). This study examined age-related variability in abnormal parathyroid gland localization for targeted PTX and the value of IPM across age groups.

Methods

A retrospective review examined prospectively collected data of 833 patients who underwent targeted PTX guided by IPM. The patients were stratified into three age groups as follows: younger [<47 years; mean −1 standard deviation (SD)], typical (47–73 years), and older (>73 years; mean +1 SD) based on an age distribution curve for pHPT. The accuracy, sensitivity, and positive predictive value (PPV) for MIBI, SUS, and IPM were analyzed and compared among age groups. Operative success was defined as eucalcemia for 6 months or longer after PTX, and operative failure was defined as elevated calcium and PTH levels within 6 months after PTX.

Results

Of the 833 patients, the youngest group had the highest accuracy and sensitivity for MIBI, SUS, and IPM compared with the older groups (p < 0.05). The accuracy and sensitivity of MIBI and SUS also decreased significantly with increased age (p < 0.05). Within all three age groups, IPM was consistently more accurate and sensitive than SUS or MIBI (p < 0.05).

Conclusions

Age can significantly affect the accuracy and sensitivity of MIBI and SUS in targeted PTX for patients with pHPT. Across all age groups, IPM remains more accurate than preoperative localization studies. For the elderly, in whom multiglandular disease appears increased, surgeons should have a lower threshold for conversion to bilateral neck exploration.
Literature
1.
go back to reference Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21:171–7.PubMedCrossRef Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21:171–7.PubMedCrossRef
2.
go back to reference Miller BS, Dimick J, Wainess R, Burney RE. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg. 2008;32:795–9.PubMedCrossRef Miller BS, Dimick J, Wainess R, Burney RE. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg. 2008;32:795–9.PubMedCrossRef
3.
go back to reference Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL III, Lew JI. Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res. 2009;155:100–103.PubMedCrossRef Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL III, Lew JI. Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res. 2009;155:100–103.PubMedCrossRef
4.
go back to reference Richert L, Trombetti A, Herrmann FR, Triponez F, Meier C, Robert JH, et al. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly. 2009;139:400–4.PubMed Richert L, Trombetti A, Herrmann FR, Triponez F, Meier C, Robert JH, et al. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly. 2009;139:400–4.PubMed
6.
go back to reference Centers for Disease Control and Prevention. Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:101–24. Centers for Disease Control and Prevention. Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:101–24.
7.
8.
go back to reference Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 Consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–80.PubMedCrossRef Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 Consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–80.PubMedCrossRef
9.
go back to reference Irvin GL III, Deriso GT III. A new, practical intraoperative parathyroid hormone assay. Am J Surg. 1994;168:466–8.PubMedCrossRef Irvin GL III, Deriso GT III. A new, practical intraoperative parathyroid hormone assay. Am J Surg. 1994;168:466–8.PubMedCrossRef
10.
go back to reference Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665–70; (discussion 670–662). Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665–70; (discussion 670–662).
11.
go back to reference Westerdahl J, Lindblom P, Bergenfelz A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg. 2002;137:186–90.PubMedCrossRef Westerdahl J, Lindblom P, Bergenfelz A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg. 2002;137:186–90.PubMedCrossRef
12.
go back to reference Irvin GL III, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239:704–8; (discussion 708–11). Irvin GL III, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239:704–8; (discussion 708–11).
13.
go back to reference Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472–8; (discussion 478–9). Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472–8; (discussion 478–9).
14.
go back to reference Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–7; (discussion 587–90). Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–7; (discussion 587–90).
15.
go back to reference Reeder SB, Desser TS, Weigel RJ, Jeffrey RB. Sonography in primary hyperparathyroidism: review with emphasis on scanning technique. J Ultrasound Med. 2002;21:539–52; (quiz 553–534). Reeder SB, Desser TS, Weigel RJ, Jeffrey RB. Sonography in primary hyperparathyroidism: review with emphasis on scanning technique. J Ultrasound Med. 2002;21:539–52; (quiz 553–534).
16.
go back to reference Van Husen R, Kim LT. Accuracy of surgeon-performed ultrasound in parathyroid localization. World J Surg. 2004;28:1122–6.PubMedCrossRef Van Husen R, Kim LT. Accuracy of surgeon-performed ultrasound in parathyroid localization. World J Surg. 2004;28:1122–6.PubMedCrossRef
17.
go back to reference Kairys JC, Daskalakis C, Weigel RJ. Surgeon-performed ultrasound for preoperative localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. World J Surg. 2006;30:1658–63; (discussion 1664). Kairys JC, Daskalakis C, Weigel RJ. Surgeon-performed ultrasound for preoperative localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. World J Surg. 2006;30:1658–63; (discussion 1664).
18.
go back to reference Solorzano CC, Carneiro-Pla DM, Irvin GL III. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg. 2006;202:18–24.PubMedCrossRef Solorzano CC, Carneiro-Pla DM, Irvin GL III. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg. 2006;202:18–24.PubMedCrossRef
19.
go back to reference Jabiev AA, Lew JI, Solorzano CC. Surgeon-performed ultrasound: a single-institution experience in parathyroid localization. Surgery. 2009;146:569–75; (discussion 575–567). Jabiev AA, Lew JI, Solorzano CC. Surgeon-performed ultrasound: a single-institution experience in parathyroid localization. Surgery. 2009;146:569–75; (discussion 575–567).
20.
go back to reference Untch BR, Adam MA, Scheri RP, Bennett KM, Dixit D, Webb C, et al. Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg. 2011;212:522–9; (discussion 529–531). Untch BR, Adam MA, Scheri RP, Bennett KM, Dixit D, Webb C, et al. Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg. 2011;212:522–9; (discussion 529–531).
21.
go back to reference Chen H, Mack E, Starling JR. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242:375–80; (discussion 380–373). Chen H, Mack E, Starling JR. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242:375–80; (discussion 380–373).
22.
go back to reference Jannasch O, Voigt C, Reschke K, Lippert H, Mroczkowski P. Comparison of outcome between older and younger patients following surgery for primary hyperparathyroidism. Pol Przegl Chir. 2013;85:598–604.PubMed Jannasch O, Voigt C, Reschke K, Lippert H, Mroczkowski P. Comparison of outcome between older and younger patients following surgery for primary hyperparathyroidism. Pol Przegl Chir. 2013;85:598–604.PubMed
23.
go back to reference Irvin GL III, Carneiro DM. Management changes in primary hyperparathyroidism. JAMA. 2000;284:934–6.PubMedCrossRef Irvin GL III, Carneiro DM. Management changes in primary hyperparathyroidism. JAMA. 2000;284:934–6.PubMedCrossRef
24.
go back to reference Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9.PubMedPubMedCentralCrossRef Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9.PubMedPubMedCentralCrossRef
25.
go back to reference Oltmann SC, Rajaei MH, Sippel RS, Chen H, Schneider DF. Primary hyperparathyroidism across the ages: presentation and outcomes. J Surg Res. 2014;190:185–90.PubMedCrossRef Oltmann SC, Rajaei MH, Sippel RS, Chen H, Schneider DF. Primary hyperparathyroidism across the ages: presentation and outcomes. J Surg Res. 2014;190:185–90.PubMedCrossRef
26.
go back to reference Oltmann SC, Schneider DF, Sippel RS, Chen H. Presentation, management, and outcomes of hyperparathyroidism in octogenarians and nonagenarians. Ann Surg Oncol. 2013;20:4195–9.PubMedCrossRef Oltmann SC, Schneider DF, Sippel RS, Chen H. Presentation, management, and outcomes of hyperparathyroidism in octogenarians and nonagenarians. Ann Surg Oncol. 2013;20:4195–9.PubMedCrossRef
27.
go back to reference Chen H, Parkerson S, Udelsman R. Parathyroidectomy in the elderly: do the benefits outweigh the risks? World J Surg. 1998;22:531–5; (discussion 535–6). Chen H, Parkerson S, Udelsman R. Parathyroidectomy in the elderly: do the benefits outweigh the risks? World J Surg. 1998;22:531–5; (discussion 535–6).
28.
go back to reference Starker LF, Fonseca AL, Carling T, Udelsman R. Minimally invasive parathyroidectomy. Int J Endocrinol. 2011;2011:206502. Starker LF, Fonseca AL, Carling T, Udelsman R. Minimally invasive parathyroidectomy. Int J Endocrinol. 2011;2011:206502.
29.
go back to reference Kebebew E, Duh QY, Clark OH. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg. 2003;138:867–71.PubMedCrossRef Kebebew E, Duh QY, Clark OH. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg. 2003;138:867–71.PubMedCrossRef
30.
go back to reference Joshua B, Feinmesser R, Ulanovski D, Gilat H, Sulkes J, Eshed V, et al. Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg. 2004;131:628–32.PubMedCrossRef Joshua B, Feinmesser R, Ulanovski D, Gilat H, Sulkes J, Eshed V, et al. Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg. 2004;131:628–32.PubMedCrossRef
31.
go back to reference Molinari AS, Irvin GL III,, Deriso GT, Bott L. Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion. Surgery. 1996;120:934–6; (discussion 936–7). Molinari AS, Irvin GL III,, Deriso GT, Bott L. Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion. Surgery. 1996;120:934–6; (discussion 936–7).
32.
go back to reference Lew JI, Irvin GL III. Focused parathyroidectomy guided by intraoperative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome. Surgery. 2009;146:1021–7.PubMedCrossRef Lew JI, Irvin GL III. Focused parathyroidectomy guided by intraoperative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome. Surgery. 2009;146:1021–7.PubMedCrossRef
33.
go back to reference Mekel M, Gilshtein H, Chapchay K, Bishara B, Krausz MM, Freund HR, et al. Parathyroid surgery in the elderly: should minimally invasive surgery be abandoned? Ann Surg Oncol. 2014;21:1369–73.PubMedCrossRef Mekel M, Gilshtein H, Chapchay K, Bishara B, Krausz MM, Freund HR, et al. Parathyroid surgery in the elderly: should minimally invasive surgery be abandoned? Ann Surg Oncol. 2014;21:1369–73.PubMedCrossRef
Metadata
Title
Intraoperative Parathormone Monitoring Mitigates Age-Related Variability in Targeted Parathyroidectomy for Patients with Primary Hyperparathyroidism
Authors
Brian Bishop, BS
Bo Wang, MD
Punam P. Parikh, MD
John I. Lew, MD, FACS
Publication date
01-12-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4843-2

Other articles of this Special Issue 3/2015

Annals of Surgical Oncology 3/2015 Go to the issue